We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04223856
Brief Title: Enfortumab Vedotin and Pembrolizumab vs. Chemotherapy Alone in Untreated Locally Advanced or Metastatic Urothelial Cancer (EV-302)

First Submitted : January 6, 2020
First Submitted that Met QC Criteria : January 8, 2020
First Posted : January 10, 2020

Last Update Submitted that Met QC Criteria : January 23, 2023
Last Update Posted : January 25, 2023